Back
Avalo Therapeutics, Inc. 10K Form
Buy
53
AVTX
Avalo Therapeutics, Inc.
Last Price:
$17.92
Seasonality Move:
9.29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AVTX News And Ratings
See the #1 stock for the next 7 days that we like better than AVTX
AVTX Financial Statistics
Sales & Book Value
| Annual Sales: | $441K |
|---|---|
| Cash Flow: | $-16.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.14 |
| Price / Book: | 3.56 |
Profitability
| EPS (TTM): | -8.72990 |
|---|---|
| Net Income (TTM): | $-99.9M |
| Gross Margin: | $638K |
| Return on Equity: | -105.25% |
| Return on Assets: | -78.1% |
Avalo Therapeutics, Inc. Earnings Forecast
Key Avalo Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 12 years for AVTX is 144.67%.
-
The Selling, General & Administrative Expenses for AVTX have been equal to 3,909.52% of Gross Profit Margin.
-
The Research & Development expenses have been 5,541.27% of Revenue.
-
The Net Earning history of AVTX is -7,965.76% of Total Revenues.
-
Per Share Earnings over the last 12 years have been positive in 8 years.
Avalo Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AVTX |
| Website: | avalotx.com |
Debt
| Debt-to-Equity Ratio: | 0.03 |
|---|---|
| Current Ratio: | 14.28 |
| Quick Ratio: | 14.01 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
AVTX Technical Analysis vs Fundamental Analysis
Buy
53
Avalo Therapeutics, Inc. (AVTX)
is a Buy
Is Avalo Therapeutics, Inc. a Buy or a Sell?
-
Avalo Therapeutics, Inc. stock is rated a BuyThe current Avalo Therapeutics, Inc. [AVTX] share price is $17.95. The Score for AVTX is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.